347 related articles for article (PubMed ID: 23733779)
21. Adjuvant chemohormonal therapy with cyclophosphamide, doxorubicin and 5-fluorouracil (CAF) with or without medroxyprogesterone acetate for node-positive breast cancer patients.
Hupperets PS; Wils J; Volovics L; Schouten L; Fickers M; Bron H; Schouten HC; Jager J; Smeets J; de Jong J
Ann Oncol; 1993 Apr; 4(4):295-301. PubMed ID: 8518219
[TBL] [Abstract][Full Text] [Related]
22. Concurrent chemo-radiotherapy following neoadjuvant chemotherapy in locally advanced breast cancer.
Alvarado-Miranda A; Arrieta O; Gamboa-Vignolle C; Saavedra-Perez D; Morales-Barrera R; Bargallo-Rocha E; Zinser-Sierra J; Perez-Sanchez V; Ramirez-Ugalde T; Lara-Medina F
Radiat Oncol; 2009 Jul; 4():24. PubMed ID: 19591689
[TBL] [Abstract][Full Text] [Related]
23. Combining Clinical and Pathologic Staging Variables Has Prognostic Value in Predicting Local-regional Recurrence Following Neoadjuvant Chemotherapy for Breast Cancer.
Vila J; Teshome M; Tucker SL; Woodward WA; Chavez-MacGregor M; Hunt KK; Mittendorf EA
Ann Surg; 2017 Mar; 265(3):574-580. PubMed ID: 27735826
[TBL] [Abstract][Full Text] [Related]
24. Male breast cancer: Outcome with adjuvant treatment.
Yadav BS; Sharma SC; Singh R; Dahiya D; Ghoshal S
J Cancer Res Ther; 2020; 16(6):1287-1293. PubMed ID: 33342786
[TBL] [Abstract][Full Text] [Related]
25. 5-Fluorouracil, adriamycin and cyclophosphamide combined with high-dose medroxyprogesterone acetate in advanced breast cancer.
Lopez M; Di Lauro L; Perno CF; Papaldo P; Barduagni M; Barduagni A
Tumori; 1983 Dec; 69(6):545-51. PubMed ID: 6229920
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of high-dose versus standard FAC chemotherapy for advanced breast cancer in protected environment units: a prospective randomized study.
Hortobagyi GN; Bodey GP; Buzdar AU; Frye D; Legha SS; Malik R; Smith TL; Blumenschein GR; Yap HY; Rodriguez V
J Clin Oncol; 1987 Mar; 5(3):354-64. PubMed ID: 3819804
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of microtubule-associated protein-Tau expression as a prognostic and predictive marker in the NSABP-B 28 randomized clinical trial.
Pusztai L; Jeong JH; Gong Y; Ross JS; Kim C; Paik S; Rouzier R; Andre F; Hortobagyi GN; Wolmark N; Symmans WF
J Clin Oncol; 2009 Sep; 27(26):4287-92. PubMed ID: 19667268
[TBL] [Abstract][Full Text] [Related]
28. Relationship of variations in tumor cell kinetics induced by primary chemotherapy to tumor regression and prognosis in locally advanced breast cancer.
Gardin G; Alama A; Rosso R; Campora E; Repetto L; Pronzato P; Merlini L; Naso C; Camoriano A; Meazza R
Breast Cancer Res Treat; 1994; 32(3):311-8. PubMed ID: 7865857
[TBL] [Abstract][Full Text] [Related]
29. Role of adjuvant chemotherapy in male breast cancer.
Patel HZ; Buzdar AU; Hortobagyi GN
Cancer; 1989 Oct; 64(8):1583-5. PubMed ID: 2676137
[TBL] [Abstract][Full Text] [Related]
30. A randomized trial comparing 12 weeks versus 36 weeks of adjuvant chemotherapy in stage II breast cancer.
Levine MN; Gent M; Hryniuk WM; Bramwell V; Abu-Zahra H; DePauw S; Arnold A; Findlay B; Levin L; Skillings J
J Clin Oncol; 1990 Jul; 8(7):1217-25. PubMed ID: 2193119
[TBL] [Abstract][Full Text] [Related]
31. Comparative Toxicity and Effectiveness of Trastuzumab-Based Chemotherapy Regimens in Older Women With Early-Stage Breast Cancer.
Reeder-Hayes KE; Meyer AM; Hinton SP; Meng K; Carey LA; Dusetzina SB
J Clin Oncol; 2017 Oct; 35(29):3298-3305. PubMed ID: 28727517
[TBL] [Abstract][Full Text] [Related]
32. Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: preliminary results of a randomised trial: S6.
Scholl SM; Fourquet A; Asselain B; Pierga JY; Vilcoq JR; Durand JC; Dorval T; Palangié T; Jouve M; Beuzeboc P
Eur J Cancer; 1994; 30A(5):645-52. PubMed ID: 8080680
[TBL] [Abstract][Full Text] [Related]
33. Inflammatory carcinoma of the breast: results of a combined-modality approach--M.D. Anderson Cancer Center experience.
Koh EH; Buzdar AU; Ames FC; Singletary SE; McNeese MD; Frye D; Holmes FA; Fraschini G; Hug V; Theriault RL
Cancer Chemother Pharmacol; 1990; 27(2):94-100. PubMed ID: 2249339
[TBL] [Abstract][Full Text] [Related]
34. Combination chemotherapy for metastatic breast cancer with fluorouracil, adriamycin, cyclophosphamide, and methotrexate.
Aboud A; Buzdar AU; Yap HY; Hortobagyi GN; Blumenschein GR
J Surg Oncol; 1984 Jul; 26(3):205-7. PubMed ID: 6610802
[TBL] [Abstract][Full Text] [Related]
35. Is drug-induced toxicity a good predictor of response to neo-adjuvant chemotherapy in patients with breast cancer?--a prospective clinical study.
Chintamani ; Singhal V; Singh JP; Lyall A; Saxena S; Bansal A
BMC Cancer; 2004 Aug; 4():48. PubMed ID: 15310398
[TBL] [Abstract][Full Text] [Related]
36. Adjuvant chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide, with or without Bacillus Calmette-Guerin and with or without irradiation in operable breast cancer. A prospective randomized trial.
Buzdar AU; Blumenschein GR; Smith TL; Powell KC; Hortobagyi GN; Yap HY; Schell FC; Barnes BC; Ames FC; Martin RG
Cancer; 1984 Feb; 53(3):384-9. PubMed ID: 6362814
[TBL] [Abstract][Full Text] [Related]
37. Results of initial doxorubicin, 5-fluorouracil, and cyclophosphamide combination chemotherapy for inflammatory carcinoma of the breast.
Maloisel F; Dufour P; Bergerat JP; Herbrecht R; Duclos B; Boilletot A; Giron C; Jaeck D; Haennel P; Jung G
Cancer; 1990 Feb; 65(4):851-5. PubMed ID: 2153434
[TBL] [Abstract][Full Text] [Related]
38. An intensive sequenced adjuvant chemotherapy regimen for breast cancer.
Bhardwaj S; Holland JF; Norton L
Cancer Invest; 1993; 11(1):6-9. PubMed ID: 8422597
[TBL] [Abstract][Full Text] [Related]
39. Noninvasive cardiac evaluation of patients receiving adriamycin-containing adjuvant chemotherapy (FAC) for stage II or III breast cancer.
Ali MK; Buzdar AU; Ewer MS; Cheng RS; Haynie TP
J Surg Oncol; 1983 Jul; 23(3):212-6. PubMed ID: 6865442
[TBL] [Abstract][Full Text] [Related]
40. Is chemotherapy effective in reducing the local failure rate in patients with operable breast cancer?
Buzdar AU; McNeese MD; Hortobagyi GN; Smith TL; Kau S; Fraschini G; Hug V; Ellerbroek N; Holmes FA; Ames F
Cancer; 1990 Feb; 65(3):394-9. PubMed ID: 2297630
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
